Last updated: May 29, 2026

Application No. 18/437,185

GENERATING CIK NKT CELLS FROM CORD BLOOD

Final Rejection

Filed

Feb 08, 2024

Priority

Jul 10, 2018 — provisional 62/696,131 +3 more

Examiner

BELYAVSKYI, MICHAIL A

Art Unit

1644

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Immunitybio Inc.

OA Round

2 (Final)

This examiner grants 64% of cases after interview

— +27.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1100 resolved cases, 2023–2026

Examiner Intelligence

BELYAVSKYI, MICHAIL A View full profile →

Grants 64% of resolved cases

Career Allowance Rate

702 granted / 1100 resolved

+3.8% vs TC avg

Strong +28% interview lift

Without

With

+27.5%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

58 currently pending

Career history

1174

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

34.2%

-5.8% vs TC avg

§102

11.2%

-28.8% vs TC avg

§112

12.5%

-27.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1100 resolved cases

Prosecution Timeline

Feb 08, 2024

Application Filed

May 16, 2025

Non-Final Rejection mailed

Aug 04, 2025

Response Filed

Sep 04, 2025

Final Rejection mailed

May 04, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/817,273

Patent 12636318

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

3y 9m to grant Granted May 26, 2026

17/936,811

Patent 12637659

EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT GAMMA DELTA T CELLS AND USES OF THESE CELLS

3y 8m to grant Granted May 26, 2026

18/246,083

Patent 12636378

TARGETED ANTIGEN DELIVERY SYSTEM AND USES THEREOF

3y 2m to grant Granted May 26, 2026

17/817,239

Patent 12622927

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

3y 9m to grant Granted May 12, 2026

17/047,516

Patent 12612602

PRODUCTION OF A BIOENGINEERED LUNG

5y 6m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

64%

Grant Probability

91%

With Interview (+27.5%)

3y 1m (~10m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 1100 resolved cases by this examiner. Grant probability derived from career allowance rate.